Abstract:Mohamed Mahmud E Aldeeb, 1, 2, &ast Gofarana Wilar, 3, &ast Cecep Suhandi, 1, &ast Khaled M Elamin, 4, &ast Nasrul Wathoni 1, &ast 1 Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia; 2 Department of Pharmaceutics, Faculty of Pharmacy, Elmergib University, Alkhoms, 40414, Libya; 3 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia; 4 Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan &astThese authors contributed equally to this work Correspondence: Nasrul Wathoni, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia, Tel +62-22-842-888-888, Email Nanosuspensions have garnered recent attention as a promising strategy for mitigating the bioavailability challenges of hydrophobic drugs, particularly those characterized by poor solubility in both aqueous and organic environments. Addressing solubility issues associated with poorly water-soluble drugs has largely resolved the need to enhance drug absorption and bioavailability. As mucosal formulations and topical administration progress in the future, nanosuspension drug delivery, straightforward formulation techniques, and versatile applications will continue to be subjects of interest. Nanosuspensions have undergone extensive scrutiny in preparation for topical applications, encompassing ocular, pulmonary, and dermal usage. Among the numerous methods aimed at improving cutaneous application, nanocrystals represent a relatively recent yet profoundly intriguing approach. Despite the increasing availability of various nanosuspension products, primarily designed for oral administration, only a limited number of studies have explored skin permeability and drug accumulation in the context of nanosuspensions. Nevertheless, the scant published research unequivocally underscores the potential of this approach for enhancing cutaneous bioavailability, particularly for active ingredients with low to medium solubility. Nanocrystals exhibit increased skin adhesiveness in addition to heightened saturation solubility and dissolution rate, thereby augmenting cutaneous distribution. The article provides a comprehensive overview of nanosuspensions for topical application. The methodology employed is robust, with a well-defined experimental design; however, the limited sample size raises concerns about the generalizability of the findings. While the results demonstrate promising outcomes in terms of enhanced drug delivery, the discussion falls short of addressing certain limitations. Additionally, the references largely focus on recent studies, but a more diverse inclusion of historical perspectives could offer a more holistic view of the subject. Keywords: nanosuspension, nanotechnology, topical, dermal Over the past two decades, there has been a notable emergence of cutting-edge advancements in the realm of pharmaceutical research and development. The automation of the drug discovery process, facilitated by technologies such as high-throughput screening, combinatorial chemistry, and computer-aided drug design, has resulted in the generation of a substantial array of highly effective drug candidates. 1 Regrettably, a considerable proportion of these promising medications grapple with the challenge of low water solubility, with approximately 40% of drugs in the developmental pipeline encountering solubility issues. 2,3 High-throughput screening techniques have contributed to the identification of an increasing number of drugs exhibiting limited water solubility. The constrained solubility of these compounds poses a significant impediment during the initial phases of screening for pharmacological activity, as well as throughout the formulation development and clinical testing processes. 4 Preparing one of these substances for preclinical investigations and pharmacological activity assessments is a prerequisite well in advance of their commercialization. 5 Consequently, it becomes evident that the adoption of innovative technical strategies is imperative to augment the bioavailability of drugs characterized by low solubility. The predominant challenge faced by the pharmaceutical industry resides in the development of novel formulation procedures and drug delivery technologies tailored to effectively address the solubility limitations associated with therapeutic candidates. These concerns frequently intersect with issues pertaining to low oral bioavailability. 6–8 To atta -Abstract Truncated-

Influence of drug physicochemical characteristics on in vitro transdermal absorption of hydrophobic drug nanosuspensions

Percutaneous permeability of cinnamon volatile oil niosomes

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study

Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics

Release Characterization of Drugs in Hot-melt Pressure Sensitive Adhesive

The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs

Nanosuspension for Parenteral Delivery of a P-Terphenyl Derivative: Preparation, Characteristics and Pharmacokinetic Studies.

A mini review of nanosuspensions development.

Surface Enrichment and Depletion of the Active Ingredient in Spray Dried Amorphous Solid Dispersions

Study on the transdermal penetration mechanism of ibuprofen nanoemulsions

Spatiotemporal fate of nanocarriers-embedded dissolving microneedles: the impact of needle dissolving rate

Enhanced transdermal delivery of curcumin nanosuspensions: A mechanistic study based on co-localization of particle and drug signals

Characterizing the Physicochemical Properties of Two Weakly Basic Drugs and the Precipitates Obtained from Biorelevant Media

Nanosuspension-Based Drug Delivery Systems for Topical Applications

Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol

Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics

Characterization and In vitro Release & In vivo Behavior Study of Self-Assembled Nano-Emulsion in XiaoYao Pill for Enhanced Drug Delivery

Skin permeation of curcumin nanocrystals: effect of particle size, delivery vehicles, and permeation enhancer

Impact of Physiological Characteristics on Chylomicron Pathway-Mediated Absorption of Nanocrystals in the Pediatric Population

Vehicle Effect on In-Vitro and In-Vivo Performance of Spray Dry Dispersions